Dr Sarah Jenkins shares a case study using polynucleotides to treat the genitourinary syndrome of menopause
Perimenopausal, menopausal and post-birth women often present with vulval skin changes causing dryness, itching, lack of natural lubrication, changes to ‘normal discharge’, painful sex and urinary leakage. 1,2
When I was working in the NHS, the only approved treatments I could offer were topical oestrogen and physiotherapy, and often these solutions fail or even exacerbate symptoms.3 I found many women would say the oestrogen makes the skin more sensitised and did not reduce symptoms, and even when they could see a menopause specialist via the NHS, I encountered that utrogestan tablets administered intravaginally may exacerbate mild prolapses and vaginal atrophy.4
While working in private practice, I wanted to be able to offer my patients a treatment option which can provide improved symptoms and ameliorated quality of life. Polynucleotides became the option I opted to explore due to the…